Laboratory testing for platelet function disorders

International Journal of Laboratory Hematology

Volumn 37, Issue S1, 2015, Pages 18-24

  Israels, S J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Clinical laboratory techniques standards; Platelet aggregation; Platelet disorders; Platelet function tests; Thrombocytopenia

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; CALCIMYCIN; COLLAGEN RELATED PEPTIDE; COLLAGEN TYPE 1; PEPTIDE; RISTOCETIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ANAMNESIS; ASPIRIN LIKE DEFECT; BERNARD SOULIER DISEASE; BLEEDING TIME; CELL STRUCTURE; CLINICAL EVALUATION; CLINICAL LABORATORY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GLANZMANN DISEASE; GRAY PLATELET SYNDROME; HEMATOLOGY ANALYZER; HEMOSTASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LIGHT TRANSMISSION AGGREGOMETRY; MOLECULAR DIAGNOSTICS; PLATELET AGGREGATION ASSAY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; THROMBOCYTE AGGLUTINATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE; WHOLE BLOOD AGGREGOMETRY; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD PLATELET DISORDERS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS;

EID: 84929379507     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12346     Document Type: Review

References (32)

1. Christie DJ, Avari T, Carrington LR, Cohen E, DeBiase BA, Harrison P, Kickler TS, Kottke-Marchant K, Ledford-Kraemer M, Rand ML, Schmaier AH, McCabe White M. Plate-let Function Testing by Aggregometry; Approved Guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2008; 28:1-45.
2. Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S, British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011;155:30-44.
3. Hayward CP, Moffat KA, Raby A, Israels S, Plumhoff E, Flynn G, Zehnder JL. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010;134:955-63.
4. Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, Lussana F, Pugliano MT, Michelson AD. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 2013;11:1183-9.
5. Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Resu-lts of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009;7:1029.
6. Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CP. North American Specialized Coagulation Laboratory A. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005;93:549-53.
7. Ruggeri ZM, Jackson SP. Platelet thrombus formation in flowing blood. In: Platelets, 3rd edn. Michelson AD (ed.). London: Academic Press, 2013: 399-424.
8. Israels SJ, Rand ML. What we have learned from inherited platelet disorders. Pediatr Blood Cancer 2013;60(Suppl 1):S2-7.
9. Rydz N, James PD. The Evolution and value of bleeding assessment tools. J Thromb Haemost 2012;10:2223-9.
10. Lowe GC, Lordkipanidze M, Watson SP. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 2013;11:1663-8.
11. Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010;48:579-98.
12. Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML. Platelet disorders in children: a diagnostic approach. Pediatr Blood Cancer 2011;56:975-83.
13. Lambert MP. What to do when you suspect an inherited platelet disorder. Hematology Am Soc Hematol Educ Program 2011;2011:377-83.
14. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol 2007;29:77-91.
15. Nurden AT, Nurden P. Congenital platelet disorders and understanding of platelet function. Br J Haematol 2014;165:165-78.
16. Cattaneo M. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature? J Thromb Haemost 2004;2:890-1.
17. Quiroga T, Goycoolea M, Munoz B, Morales M, Aranda E, Panes O, Pereira J, Mezzano D. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2004;2:892-8.
18. Jackson SC, Sinclair GD, Cloutier S, Duan Z, Rand ML, Poon MC. The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation. Blood 2009;113:3348-51.
19. Hayward CP, Moffat KA, Pai M, Liu Y, Seecharan J, McKay H, Webert KE, Cook RJ, Heddle NM. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost 2008;100:134-45.
20. Cattaneo M, Lecchi A, Zighetti ML, Lussana F. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica 2007;92:694-7.
21. Castilloux JF, Moffat KA, Liu Y, Seecharan J, Pai M, Hayward CP. A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples? Thromb Haemost 2011;106:675-82.
22. Hayward CP, Pai M, Liu Y, Moffat KA, Seecharan J, Webert KE, Cook RJ, Heddle NM. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009;7:676-84.
23. Dawood BB, Lowe GC, Lordkipanidze M, Bem D, Daly ME, Makris M, Mumford A, Wilde JT, Watson SP. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood 2012;120:5041-9.
24. McGlasson DL, Fritsma GA. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 2009;35:168-80.
25. Peerschke EI, Castellone DD, Stroobants AK, Francis J. Reference range determination for whole-blood platelet aggregation using the multiplate analyzer. Am J Clin Pathol 2014;142:647-56.
26. Pai M, Wang G, Moffat KA, Liu Y, Seecharan J, Webert K, Heddle N, Hayward C. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 2011;136:350-8.
27. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009;35:158-67.
28. White JG. Electron microscopy methods for studying platelet structure and function. Methods Mol Biol 2004;272:47-63.
29. Harrison P, Lordkipanidze M. Testing platelet function. Hematol Oncol Clin North Am 2013;27:411-41.
30. Bunimov N, Fuller N, Hayward CP. Genetic loci associated with platelet traits and platelet disorders. Semin Thromb Hemost 2013;39:291-305.
31. Lordkipanidze M, Lowe GC, Kirkby NS, Chan MV, Lundberg MH, Morgan NV, Bem D, Nisar SP, Leo VC, Jones ML, Mundell SJ, Daly ME, Mumford AD, Warner TD, Watson SP, UK Genotyping and Phenotyping of Platelets Study Group. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood 2014;123:e11-22.
32. Hayward CP, Moffat KA, Plumhoff E, Timleck M, Hoffman S, Spitzer E, Van Cott EM, Meijer P. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost 2012;38:622-31.